Pro-Dex Inc (PDEX) - Cumulative Company Assets

Public company logo of Pro-Dex Inc (PDEX)

The market for specialized surgical motors is characterized by steady demand, which is driving the growth of the Pro-Dex, Inc. (PDEX) client base. This chart of total asset price action, valued at 69.34, confirms the market valuation and illustrates the development of the tool ecosystem for maxillofacial surgeries. Business stability is underpinned by the production of precision drives deeply integrated into the equipment of leading med-tech brands, making it virtually impossible for clients to switch providers.

Pro-Dex Inc (PDEX) Company Total Assets: for the period 07/04/2022 - 10/27/2026

Comprehensive metric breakdowns and analytics for Pro-Dex Corp (PDEX)

- price and consensus price forecast:
Share Price pro-dex.com|PDEX - Price Target Chart
- market capitalization data:
Market Valuation Pro-Dex Inc.|PDEX - Enterprise Value
- book capitalization data:
Net Asset Value per Share Pro-Dex|PDEX - Book Capitalization|Capitalization to Book Value Ratio pro-dex.com|PDEX - Company Total Assets
- debt and liquidity data:
Total Debt to Capital Coefficient Pro-Dex, Inc.|PDEX - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio Pro-Dex Inc.|PDEX - Company Aggregate Debts|Debts to Book Capitalization Pro-Dex Inc.
Fundamental valuation:pro-dex.com, PDEX
Manufactured product of Pro-Dex, Inc.

Total assets, reverse-calculated via ROA, demonstrate the actual volume of Pro-Dex, Inc. (PDEX) resources, stripped of market noise and price volatility. By analyzing the history of balance sheet assets for Pro-Dex, Inc. (PDEX), an investor can assess the base's resilience to regulatory pressure risks and the dependence of revenues on hospital government budgets, which allows for the identification of hidden capital freezes amid unstable demand for surgical instrumentation.

Main competitors

ISRG (intuitive.com) - Total Business Assets|Aggregate Company Assets DHR|Cumulative Company Assets BD|STERIS Corporation - Company Total Assets|Company Assets West Pharma Corp (WST)|BAX - Company Total Assets|Total Business Assets masimo.com MASI|Company Total Assets STVN (Stevanato Group)|TFX - Company Total Asset Base|MMSI (Merit Medical Systems Inc) - Company Total Assets|Nobel Biocare (NVST) - Cumulative Company Assets|ICUI (ICU Medical, Inc.) - Company Total Assets|Company Total Assets XRAY|Aggregate Company Assets LeMaitre Vascular (LMAT)|Aggregate Company Assets AtriCure Inc ATRC|Cumulative Company Assets STAAR Surgical Corp|Aggregate Asset Value ChromaDex NAGE|Company Total Assets ZIMV (ZimVie Inc.)|ANGO: Company Total Asset Base|Aggregate Company Assets Cerus|TKNO (Alpha Teknova) - Total Business Assets|MGRM: Aggregate Company Assets|Company Total Asset Base Sharps Tech (STSS)|Cumulative Company Assets InfuSystem Holdings|Aggregate Business Assets UTMD (utahmed.com)|Aggregate Company Assets KORU Medical|NYXH - Aggregate Asset Value|Microbot Medical Inc - Cumulative Company Assets|ZTEK: Company Total Assets|ELUT (Elutia Inc.) - Aggregate Company Assets|milestonescientific.com (MLSS) - Cumulative Company Assets|Company Total Assets NXGL (NEXGEL)|Company Assets RVP|Aggregate Company Assets Harvard Bioscience HBIO|Total Business Assets Femasys Corporation FEMY|Cumulative Company Assets Meihua Medical Technologies Co., Ltd. (MHUA)|Predictive Oncology Inc - Aggregate Business Assets|Aggregate Company Assets CJMB (Callan JMB Corp)|ATRI: Company Total Asset Base|Aggregate Company Assets NeuroMetrix Corp (NURO)